bicyclol
Small moleculeexperimental
Clinical trial activity
3 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
1
Phase 4
0
Earliest trial started Apr 1, 2016 (NCT02944552)
Timeline
Indications
Mechanism of action
MYD88 antagonist
- Toll-like receptor 4ANTAGONIST
TLR4 antagonist
Chemistry & pharmacology
Loading structure…
SMILES
COC(=O)c1cc(OC)c2c(c1-c1c(CO)cc(OC)c3c1OCO3)OCO2- Mol. weight
- 390.34 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL482035 ↗
Also known as
- 6-methoxycarbonyl-6'-hydroxymethyl-2,3,2',3'-bis(methylenedioxy)-4,4'-dimethoxybiphenyl
- bicyclol
- bicyclol
- bicyclol
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05711459 | N/A | May 1, 2022 | Tianjin Medical University |
| NCT05063500 | Phase 3 | Oct 31, 2021 | Drug Induced Liver Disease Study Group, Government of China, Jiao Tong University, People's Liberation Army of China |
| NCT02944552 | Phase 2 | Apr 1, 2016 | Drug Induced Liver Disease Study Group |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Drug Induced Liver Disease Study Group | Academic/Hospital | 2 | 2 | 2 | 2016 |
| Government of China | Government | 1 | 0 | 1 | 2021 |
| Jiao Tong University | Academic/Hospital | 1 | 0 | 1 | 2021 |
| People's Liberation Army of China | Government | 1 | 0 | 1 | 2021 |
| Tianjin Medical University | Academic/Hospital | 1 | 1 | 1 | 2022 |
5 organizations
Page 1 / 1